Evidence map›Paper›PMID 39572628›Full record

Observational studyScientific reports2024

The first cross-sectional comparative observational study of sexual dysfunction in Emirati and non-Emirati Parkinson's disease patients (EmPark-SD) in the United Arab Emirates.

Vinod Metta, Huzaifa Ibrahim, Mubasher A Qamar, Rajinder K Dhamija, Karolina Popławska-Domaszewicz, Hani T S Benamer, Tom Loney, Rukmini Mrudula, Cristian Falup-Pecurariu, Carmen Rodriguez-Blazquez and 6 more

Abstract readObservational StudyComparative Study
In one paragraph

Observational study in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Vinod MettaKing's College London, Department of Neurosciences, Institute of Psychiatry, Psychology & Neuroscience and Parkinson's Foundation Centre of Excellence, King's College Hospital, London, UK. vinod.metta@nhs.net.
Huzaifa IbrahimParkinson's Association United Arab Emirates, Dubai, UAE.
Mubasher A QamarKing's College London, Department of Neurosciences, Institute of Psychiatry, Psychology & Neuroscience and Parkinson's Foundation Centre of Excellence, King's College Hospital, London, UK.
Rajinder K DhamijaInstitute of Human Behavior and Allied Sciences, Lady Hardinge Medical College and SSK Hospital, New Delhi, India.
Karolina Popławska-DomaszewiczDepartment of Neurology, Poznan University of Medical Sciences, Poznan, Poland.
Hani T S BenamerCollege of Medicine, Mohammed Bin Rashid, University of Medicine and Health Sciences, Dubai, UAE.
Tom LoneyCollege of Medicine, Mohammed Bin Rashid, University of Medicine and Health Sciences, Dubai, UAE.
Rukmini MrudulaInstitute of Movement Disorders and Parkinson's Centre, City Neuro Centre, Hyderabad, India.
Cristian Falup-PecurariuDepartment of Neurology, Transilvania University of Brasov, Brasov, Romania.
Carmen Rodriguez-BlazquezNational Centre of Epidemiology and CIBERNED, Institute of Salud Carlos III, Madrid, Spain.
Haidar S DafsariUniversity Hospital Cologne, Cologne, Germany.
Vinay GoyalInstitute of Movement Disorders and Parkinson's Centre, Medanta Hospitals, Delhi, India.
Rupam BorgohainInstitute of Movement Disorders and Parkinson's Centre, Medanta Hospitals, Delhi, India.
Shaikha AlmazroueiStemcell Society United Arab Emirates, Abu Dhabi, UAE.
Guy Chung-FayeKing's College London, Department of Neurosciences, Institute of Psychiatry, Psychology & Neuroscience and Parkinson's Foundation Centre of Excellence, King's College Hospital, London, UK.
Kallol Ray ChaudhuriKing's College London, Department of Neurosciences, Institute of Psychiatry, Psychology & Neuroscience and Parkinson's Foundation Centre of Excellence, King's College Hospital, London, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sexual dysfunction (SD) is a common non-motor symptom in people with Parkinson's disease (PD) yet underreported and undertreated specifically in many ethnic PD groups because of religious, social and personal perceptions. We conducted the first single-centre cross-sectional study in the United Arab Emirates of SD in 513 consecutive patients who agreed to complete the survey questionnaires. Data was collected on SD using the Nonmotor Symptoms Scale (NMSS), Index of Erectile Function, and Female Sexual Function Index. Our results show that the non-Emirati group had higher NMSS-SD scores than the Emirati group. SD was reported independent of ethnicity, race and disease stage (p < 0.001). SD correlated with worsening quality of life (p < 0.001) and anxiety domain, especially in young PD patients (p < 0.001). Our data concludes that there is no significant difference in SD between different ethnicity groups, contrary to common perception. SD appears to be underreported in this population and needs addressing using culturally sensitive bespoke counselling.

Indexed as

Parkinson DiseaseQuality of LifeSexual Dysfunction, PhysiologicalAdultAgedCross-Sectional StudiesFemaleHumansMaleMiddle AgedSurveys and QuestionnairesUnited Arab Emirates

Identifiers

PMID39572628
PMCPMC11582356

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.